Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women?

<div>The ROC-AUC for HE4, CA125, and ROMA for the differentiation between malignant and nonmalignant adnexal masses in the whole group (a), premenopausal subgroup (b), and postmenopausal subgroup (c).</div>

Disease Markers

fig1

Figure 1

Figure 1: Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women? 

Figure 1 | Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women? 